{"disease":{"id":"advanced-liver-cancers","name":"advanced liver cancers"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04524871","title":"A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":518,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT05098197","title":"A Study of GC101 TIL in Advanced Hepatobiliary-Pancreatic Cancers (10hospital)","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Shanghai Juncell Therapeutics","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}